US Stem Cell Inc


By |


US Stem Cell Inc is a biotechnology company engaged in the discovery, development of autologous cell therapies for the treatment of chronic and acute heart damage. Its product includes MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company's discoveries include multiple cell therapies in various stages of development that repair damaged tissues throughout the body due to injury or disease so that patients may return to a normal lifestyle.

Contact Information

Main Phone: +1 954 835-1500
Address: 13794 North West 4th Street
Address 2: Suite 212
State: FL
City / Town: Sunrise
Country: USA
Postal Code: 33325

Issuer Information

Exchange: OTCQB
CEO: Mike Tomas
Employees: 4
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 0.01855 $ -0.00095 (-4.87%)
Last Price 0.01855 Change $ -0.00095 Change % -4.87 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.0195 High 0.0195 Low 0.0181 Prev Close 0.0195
Last Trade Volume 435,146 52 Wk Hi 0.088 52 Wk Low 0.0166
Market Cap 6.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 368,152,654.00 EPS (TTM) -0.01 PE Ratio N/A Exchange OTCQB
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Samuel S. Ahn 1,000
Samuel S. Ahn 1,000
Charles A. Hart 1,000
Samuel S. Ahn 1,000
Samuel S. Ahn 1,000
Samuel S. Ahn 1,000
William P. Murphy 1,000
Last 10 Sell Shares
N/A 0